课题基金 / 基金详情

Modification of Intervertebral Disk Fatigue Resistance

Modification of Intervertebral Disk Fatigue Resistance
椎间盘抗疲劳性的改进
批准号:
6403094
负责人:
THOMAS P HEDMAN
金额:
$9.89万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2001
资助国家:
美国
项目状态:
已结题
起止时间:
2001-09-25 至 2002-09-24

项目摘要

项目成果

THOMAS P HEDMAN的其他基金

相似基金

相关文献

中文摘要
翻译
描述(由申请人提供):建议进行一项调查,探讨
英文摘要
DESCRIPTION (Provided by Applicant): An investigation is proposed exploring the use of biochemical reagents to improve fatigue resistance of intervertebral disc tissue. While not well quantified, the capacity of spinal tissue to withstand repetitive loading is a critically important factor in the progression of spinal osteoarthritis. Current treatments for spinal instability and low-back pain, including spinal fusion, are generally ineffective in slowing the progression of degeneration. Biochemical alterations in the structure of the annular matrix could have significant effects on the disc's ability to withstand repetitive mechanical loading. We intend to study the effectiveness of certain reagents in maintaining the mechanical properties of disc tissues subjected to non-traumatic fatigue loading. Preliminary experiments in our laboratory using novel destructive and non-destructive mechanical testing techniques have shown degradation of elastic-plastic and viscoelastic material properties of disc tissues subjected to non-traumatic cyclic loads. If these reagents are effective in improving fatigue resistance of intervertebral discs, a new, minimally invasive treatment may be developed which will be able to improve the degenerated disc's ability to withstand repetitive physiological loads. This type of treatment has the potential of improving or even replacing numerous surgical interventions directed at the ubiquitous problems of low back pain and instability. PROPOSED COMMERCIAL APPLICATION: Back pain and disability associated with spinal degeneration and instability is without question one of the costliest health problems in western civilization (in the range of $20 billion U.S. annually- low-back-pain alone). The commercial potential of a minimally invasive treatment (perhaps a series of injections) capable of arresting degradation and stabilizing intervertebral discs would be staggering. In addition, such treatment could be used as an additional preventative procedure in fusion surgery, where accelerated degeneration commonly occurs at the level adjacent to the fusion.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Crosslink augmentation to resist snoring and obstructive sleep apnea syndrome
  • 批准号:
    8452036
  • 项目类别:
  • 资助金额:
    $24.49万
  • 财政年份:
    2013
  • 负责人:
    THOMAS P HEDMAN
  • 依托单位:
Nonsurgical Exogenous Crosslink Therapy for Intervertebral Disc Disease
  • 批准号:
    7272176
  • 项目类别:
  • 资助金额:
    $7.07万
  • 财政年份:
    2007
  • 负责人:
    THOMAS P HEDMAN
  • 依托单位:
Injectable collagen crosslink augmentation for degenerative disc disease
  • 批准号:
    7800652
  • 项目类别:
  • 资助金额:
    $40.85万
  • 财政年份:
    2007
  • 负责人:
    THOMAS P HEDMAN
  • 依托单位:
Injectable collagen crosslink augmentation for degenerative disc disease
  • 批准号:
    8018638
  • 项目类别:
  • 资助金额:
    $35.94万
  • 财政年份:
    2007
  • 负责人:
    THOMAS P HEDMAN
  • 依托单位:
海外基金